Literature DB >> 8370177

Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) in human T cells activated by murine antigens.

S Panzer1, M Madden, K Matsuki.   

Abstract

We used a mixed leucocyte culture between human T cells and irradiated murine splenocytes which allowed us to distinguish between cytokine production from the responder and stimulator cells by the use of species-specific assays for mRNA up-regulation. Using this model of T cell activation by antigen, we studied the effects of human antigen-presenting cell-derived cytokines IL-1 beta, IL-6 and TNF-alpha on the activation of human T cell subsets. We show in this system that exogenously added IL-1 beta, IL-6 and TNF-alpha induces IL-2 receptor (R) up-regulation and IL-2 production, and proliferation by both CD4+ and CD8+ cells. The addition of IL-1 beta induces IL-6 mRNA, and anti-IL-1 antibodies or an IL-1R antagonist protein completely suppresses IL-6 and TNF-alpha supported proliferation. Similarly, addition of IL-6 or TNF-alpha induces up-regulation of IL-1 beta mRNA. However, anti-IL-6 and anti-IL-6R antibodies only partially block proliferation supported by IL-1 beta. These findings suggest that IL-6 and TNF-alpha will induce IL-2R up-regulation/IL-2 secretion via the induction of IL-1 beta production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370177      PMCID: PMC1554907          DOI: 10.1111/j.1365-2249.1993.tb08203.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Expression of interleukin 1 receptors is restricted to the L3T4+ subset of mature T lymphocytes.

Authors:  J W Lowenthal; H R MacDonald
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

2.  Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.

Authors:  H Golding; A Singer
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

3.  T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.

Authors:  A Singer; A M Kruisbeek; P M Andrysiak
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

4.  Self recognition of accessory cell Ia determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte responses.

Authors:  A M Kruisbeek; P M Andrysiak; A Singer
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

5.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 6.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

7.  Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2.

Authors:  B Endler-Jobst; B Schraven; B Hutmacher; S C Meuer
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

8.  Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.

Authors:  L Davis; P E Lipsky
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

9.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction.

Authors:  K F Lindahl; F H Bach
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

View more
  8 in total

1.  Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells.

Authors:  M Cumberbatch; R J Dearman; I Kimber
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

2.  Taurine and proliferation of lymphocytes in physically restrained rats.

Authors:  Fili Fazzino; Francisco Obregón; Lucimey Lima
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

3.  A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  A Gualberto; M L Hixon; T S Finco; N D Perkins; G J Nabel; A S Baldwin
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

Review 4.  The inflammatory response to skeletal muscle injury: illuminating complexities.

Authors:  Carine Smith; Maritza J Kruger; Robert M Smith; Kathryn H Myburgh
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

5.  Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model.

Authors:  Scott R Burks; Ali Ziadloo; Hilary A Hancock; Aneeka Chaudhry; Dana D Dean; Bobbi K Lewis; Victor Frenkel; Joseph A Frank
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

6.  Identification of women with early breast cancer by analysis of p43-positive lymphocytes.

Authors:  L Auerbach; M Hellan; M Stierer; A C Rosen; C Ausch; R Obwegeser; E Kubista; G Wolf; H R Rosen; S Panzer
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

7.  Extraction, Characterization, Antitumor and Immunological Activities of Hemicellulose Polysaccharide from Astragalus radix Herb Residue.

Authors:  Ke Li; Shuying Li; Di Wang; Xiaoxia Li; Xingkang Wu; Xiaojie Liu; Guanhua Du; Xianrong Li; Xuemei Qin; Yuguang Du
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

8.  Interleukin-1 alpha increases the preferential cytotoxicity of an interleukin-2-diphtheria toxin fusion protein against neoplastic lymphocytes from patients with the Sezary syndrome compared to normal lymphocytes.

Authors:  D Salard; T M Kuzel; E Samuelson; S Rosen; O Bakouche
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.